TMCnet News
Dont Miss Out!! :: Sign Up For Our Free Newsletter!! IWEB,MILL CBAI(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: IWEB) IceWEB, Inc., (OTCBB: MILL) Miller Petroleum, Inc., (OTCBB: CBAI) Cord Blood America, Inc., (OTCBB: BISU) Bio-Solutions Corp., (OTCBB: PHLI) PacificHealth Laboratories, Inc., (OTCBB: YESD) YesDTC Holdings, Inc. www.StockMarketingInc.com For More Information email us!! [email protected] ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: IWEB - IceWEB, Inc.) LATEST NEWS!! IceWEB Announces Details for the Inaugural IceWEB.TV Broadcast STERLING, Va., Mar 22, 2010 -- IceWEB, Inc.(TM) (OTCBB: IWEB), a leading provider of Unified Data Storage, building blocks for cloud storage networks, and purpose built appliances, is pleased to provide details for the Company's inaugural broadcast on IceWEB.TV (www.iceweb.tv). The inaugural broadcast will take place on Thursday, March 25th at 4:15 PM ET. IceWEB encourages all interested parties to join the broadcast. In order to access the broadcast via IceWEB.TV, please click the following link: www.iceweb.tv. About IceWEB, Inc. Headquartered just outside of Washington, D.C., IceWEB manufactures and markets data storage products, network and cloud storage solutions and delivers on-line cloud computing application services. Its customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB). For more information, please visit www.IceWEB.com. ************************************************************************************************** (OTCBB: MILL - Miller Petroleum, Inc.) LATEST NEWS!! Miller Energy Resources Reports $271 Million in Record Profits for the Third Quarter HUNTSVILLE, TN, Mar 24, 2010 -- Miller Petroleum, Inc. dba Miller Energy Resources (OTCBB: MILL) announced today that it had net income of $271.9 million for the third quarter ending January 31, 2010. This represents earnings for the quarter of $12.44 per outstanding share and earnings of $9.51 per fully diluted share. The net income for the quarter is a direct result of the acquisition in December 2009 of oil and gas assets from Pacific Energy Resources through a Chapter 11 U.S. Bankruptcy proceeding in which Miller acquired onshore and offshore production and processing facilities, an offshore energy platform, over 600,000 net lease acres of land with hundreds of miles of 2-D and 3-D geologic seismic data, miscellaneous roads, pads and facilities. On March 3, 2010, Miller announced that its Alaskan operations were producing more than 800 BOED and on March 15, 2010, Miller announced that it has a total proforma asset value of over $492 million, including oil and natural gas reserves valued at $372 million. "This is a historic time at Miller Energy Resources," said Scott M. Boruff, Miller CEO. "The record results for the third quarter reflect the hard work of the team that has been assembled at Miller and bodes well for our ambitious business plan moving forward. The addition of the Alaskan operations has positively impacted all facets of our company and is a true milestone for Miller as we continue to maximize value for our shareholders." About Miller Miller Energy Resources is an oil and natural gas exploration, production and drilling company operating in multiple exploration and production basins in North America. Miller's focus is in Cook Inlet, Alaska and in the heart of Tennessee's prolific and hydrocarbon-rich Appalachian Basin. Miller is headquartered in Huntsville, Tennessee with offices in Anchorage, Knoxville and New York City. The company is quoted on the OTC Bulletin Board under the symbol MILL. ************************************************************************************************** (OTCBB: CBAI - Cord Blood America, Inc.) LATEST NEWS!! Cord Blood America Acquires Controlling Interest in One of Germany's Largest Cord Blood Storage Companies LAS VEGAS, March 24, 2010 -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has acquired 51 percent of stellacure GmbH, the third largest cord blood banking service in Germany. "Europe is quickly becoming a global force in the storage of stem cells for future medical use. We believe this acquisition is a perfect example of our business strategy to use acquisitions as part of the process to grow Cord Blood America into a major stem cell storage company globally," said Matthew Schissler, Cord Blood America co-founder and CEO. stellacure (www.stellacure.com) is headquartered in Hamburg, Germany. It began storing cord blood for families in 2006 throughout Germany, and within the past year has established sales channels in Spain and Italy. It operates in conjunction with the German Red Cross Bloodservices Baden-Wuerttemberg/Hessen, which has collected cord blood for a public bank since 1996. "Becoming a 51% stakeholder of one of Europe's most meaningful stem cell banking companies is extremely important for us to carry out our goal of becoming the globally dominant stem cell storage company. We see acquiring a majority stake in stellacure as an important first step to further penetrate other European markets. CBAI is extremely pleased that it was chosen as stellacure's preferred partner to foster further growth of the company and equally excited to establish a long term relationship with the largest blood service unit of the German Red Cross, as we all know a respected name globally," Mr. Schissler said. The transaction was introduced by specialist life sciences advisory firm CFP BioConnect AG, based in Frankfurt/Germany. About Cord Blood America Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com. ************************************************************************************************** (OTCBB: BISU - Bio-Solutions Corp.) LATEST NEWS!! Bio-Solutions Corp. Announces Nomination of Another Prestigious Member to its Advisory Committee MONTREAL, QUEBEC, Mar 22, 2010 -- Bio-Solutions Corp. (OTCBB: BISU) Bio-Solutions Corp. is happy to announce that today Dr. Maximilien Arella has been appointed to Bio-Solution's advisory Board. "Dr. Max Arella is the brainchild behind the development and implementation of GreenEx, our flagship product", says President and CEO, Dr. Chaumillon. Dr. Arella is a Professor at the Microbiology and Biotechnology Research Centre, INRS - Institut Armand - Frappier, at the University du Quebec in Montreal. Dr. Arella brings with him extensive international experience in the field of molecular biology and monoclonal antibody development. Combining both an experience of researcher and entrepreneur, he is a member of various national and international committees on infectious diseases and expression of recombinant proteins. Since 1984, Dr. Arella has been scientific advisor and counsellor for Dr. Tetsuo Nakamura, president of the 'Institute of Immunology Co. Ltd.' based in Tokyo, Japan. From 1996 to 2001, Dr. Arella was a founding member and shareholder of Sapientia Therapeutics, a Canadian biotech company, active in the evaluation of an additive boosting cellular immunity. Since 1998, Dr. Arella has acted as president and shareholder of Perigene Inc, a company who owns platform technologies from INSA-Rouen and from the UTC-Compiegne in France. He also acted as president and shareholder of Sannica Biotech-Pharma since 1999, whose aim is to increase the value of certain platforms coming from Japan (University of Tokyo, Kyoto and Osaka). His academic research is mainly based in the fields of molecular biology, fundamental aspects and applications of the double-stranded RNA virus, as well as amplification systems for the analysis of human and animal viruses, and cancer markers. Since 1993, Dr. Arella carried out two mandates as chairman of the Virology Research Center of the IAF during which he held the responsibility of managing both the research and the teaching programs. Dr. Arella holds a Post-doctorate Degree in Biotechnology from the Roche Institute of Molecular Biology in New Jersey, has a Ph.D. in virology from the Institut Armand Frappier / Universite de Rouen and obtained a Master's Degree in Microbiology-Immunology from the Universite de Montreal. For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com ************************************************************************************************** (OTCBB: PHLI - PacificHealth Laboratories, Inc.) LATEST NEWS!! PacificHealth Laboratories Reports 2009 Financial Results MATAWAN, N.J., Mar 24, 2010 -- PacificHealth Laboratories, Inc. (OTCBB: PHLI), a leading nutrition company, today reported financial results for the three months and year ended December 31, 2009. Year Ended December 31 Financial Results For the year ended December 31, 2009, revenues increased 10% to $7,995,194 compared to $7,235,991 for the same period in 2008. The Company recorded a net loss of $1,676,124, or $0.11 per share, for the year 2009 compared to a net loss of $1,994,353, or $0.15 per share, for the same period in 2008. In the fourth quarter of 2009, the Company made the decision to forgo marketing its FORZE GPS(TM) weight management product line as the Company was unable to generate enough sales in 2009 to make this product line viable in the foreseeable future. As a result, the Company recorded $81,050 in non-cash restructuring charges consisting of writing off property and equipment specific to the marketing efforts of FORZE GPS and also recorded a $491,172 reserve for inventory as the value of this inventory may never be realized. As a result of a change in estimate relating to revenue recognition in connection with sales to a major customer, in 2009 the Company recognized revenues of approximately $279,000 and reduced inventory by approximately $129,000 that was previously recorded as deferred revenue and inventory, respectively. In the third quarter of 2008, the Company restructured its operations to better support its base sports performance business. As part of this restructuring, a number of positions within the Company were eliminated and certain market sectors were exited. As a result, the Company recorded $472,069 in non-cash restructuring charges and reserved $84,669 of SATIATRIM(R) finished goods as obsolete in the third quarter of 2008. In the fourth quarter of 2008, the Company also wrote off an additional $117,028 of finished goods and raw materials as obsolete. Fred Duffner, President of PacificHealth said, "PHLI focused on two key areas in 2009. First, we focused on our core businesses with an emphasis on the sports specialty channel to drive new users of our Endurance products. This resulted in improving revenue by 10% during a challenging economic year with fourth quarter growth of 24%. We believe this will provide the foundation to continue to expand our consumer base and support future growth for the company. Second was the launch of innovation under the Forze GPS brand. We realized that PHLI could not support the continued cost of entry into this highly competitive market at this time and will therefore adjust our marketing investment for 2010." Three-Month Financial Results Revenues in the fourth quarter of 2009 increased 24% to $1,198,230 compared to $969,991 for the same period in 2008. The Company recorded a net loss of $1,109,486, or $0.07 per share, compared to a net loss of $726,371, or $0.05 per share, for the same period in 2008. As noted above, in the fourth quarter of 2009, the Company recorded a restructuring charge of $81,050 and recorded a $491,172 reserve for inventory. In the fourth quarter of 2008, the Company also wrote off $117,028 of finished goods and raw materials as obsolete. About the Company: PacificHealth Laboratories, Inc. (OTCBB: PHLI) is a leading sports nutrition company that focuses on marketing, developing and selling premium nutrition tools for exercisers and athletes seeking to improve their health and performance. We are highly active in the endurance sports arena. Our brands and patents are typically protein-based and extend to cover areas such as appetite regulation. PHLI's principle areas of focus are sports performance and recovery, including optimal weight management. To learn more, visit www.pacifichealthlabs.com. ************************************************************************************************** (OTCBB: YESD - YesDTC Holdings, Inc.) LATEST NEWS!! YesDTC Announces the Appointment of William ("Bill") Bush as Chief Financial Officer SAN FRANCISCO, Mar 24, 2010 -- YesDTC Holdings, Inc. (OTCBB: YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, today announced the appointment of William ("Bill") Bush as the Company's Chief Financial Officer. Mr. Bush has over 20 years of experience in accounting, financial support and business development, including his most recent success serving as CFO of the leading manufacturer of solar panels in India, helping the company to reach $100 million in sales in its first 15 months of operation. Additionally, prior to joining YesDTC, Mr. Bush accumulated significant experience in the role of chief financial officer for several high growth software and online media companies with responsibilities for establishing business processes, capital raising, business development and investor relations. Throughout his career, he has also served in the roles of business development and corporate controller and spent seven years in public accounting with Ernst & Young and Price Waterhouse. Bill holds a B.S. in Business Administration from U.C. Berkeley and is a Certified Public Accountant. He currently serves on the Board of Towerstream, a leading supplier of WiMax services; FindEx.com, a Bible study software provider; and ThinIdentity, a private developer and distributor of virtualization solutions for the medical industry. About YesDTC Holdings, Inc. YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), Internet and retail marketing programs. The Company brings a unique set of skills to this marketplace. YesDTC combines both creative talents and financial acumen to create a total package for direct-to-consumer marketing programs. We have formed a strategic partnership with Schulberg Media Works (SMW), one of the pioneering firms in the direct-to-consumer space. SMW's track record is impressive with nearly $1 billion in revenues and a strong track record of industry awards. SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins, PureSleep, among many others. ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS |